Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia
Public ClinicalTrials.gov record NCT00972829. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Recently, research studies have shown that patients who have had trouble taking statins every day, are able to take statins if they take them only once or twice a week. The investigators are doing a research study which involves switching people who are taking ezetimibe to the statin Crestor once or twice a week and to see how ell Crestor lowers cholesterol and if it is tolerated.
Study identification
- NCT ID
- NCT00972829
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2009
- Primary completion
- Nov 30, 2010
- Completion
- Feb 28, 2011
- Last update posted
- Sep 9, 2009
2009 – 2011
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bronx VA Medical Center | The Bronx | New York | 10468 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hypercholesterolemia trials
Other public records listing Hypercholesterolemia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia Recruiting
- NCT06451770: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia Recruiting
- NCT06065098: Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health Active, not recruiting
- NCT00353782: Causes and Natural History of Dyslipidemias Recruiting
- NCT07447206: Vascular Intervention Strategies Trial for Alzheimer's Not yet recruiting
- NCT07514663: Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00972829, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2009 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00972829 live on ClinicalTrials.gov.